Archived
COGR Testimony at NIH Hearings on March-in Rights
NIH has denied the request from Essential Inventions, Inc. to exercise march-in rights under The Bayh-Dole Act in connection with the pricing of Norvir, marketed by Abbott Laboratories for the treatment of patients with HIV/AIDS. The decision and related materials are available online.
Costing Issues
COGR provides an in-depth analysis of how universities address federal requirements for effort reporting related to compensation on federally funded research awards. Triggered by recent audit findings and heightened oversight, the paper explores the relevant federal guidance—principally OMB Circular A-21 and A-110—and highlights the inherent challenges universities face in accurately tracking and
Notification Letter for 45 CFR 46.118 Determinations for NSF Awards
COGR has been working with NSF staff to develop
151904
The February 2012 COGR Meeting Report details significant developments and ongoing issues in federal research policy, especially those affecting university research administration. A major focus is the Office of Management and Budget’s (OMB) grants reform initiative, as outlined in the Advance Notice of Proposed Guidance (ANPG), which proposes consolidating multiple OMB circulars governing grants,
Timing of FCOI Reporting
The document outlines the processes and requirements for the timing and submission of Financial Conflict of Interest (FCOI) disclosures and reports in connection with NIH funding. It details that institutions must implement FCOI policies for each new grant or cooperative agreement after the compliance date, with the option to coordinate implementation across all Public Health Service (PHS) funded
